Literature DB >> 10857835

Ocular surface changes after excimer laser phototherapeutic keratectomy.

M Dogru1, C Katakami, M Miyashita, E Hida, M Uenishi, K Tetsumoto, S Kanno, T Nishida, A Yamanaka.   

Abstract

PURPOSE: To study the ocular surface disorder in patients with Avellino, granular, and lattice dystrophy, band keratopathy, and corneal leukoma before and after excimer laser phototherapeutic keratectomy.
DESIGN: A prospective case-controlled study. PARTICIPANTS: A total of 45 eyes of 33 patients with superficial corneal opacities seen at Kobe Kaisei Hospital, Department of Ophthalmology, and 40 eyes of 20 normal control subjects were studied. INTERVENTION: The subjects underwent routine ophthalmic examinations, corneal sensitivity measurements, tear film break up time (BUT), Schirmer test, tear film lipid layer interferometry, and conjunctival impression cytology. MAIN OUTCOME MEASURES: The patients and the control subjects were compared for prephototherapeutic keratectomy (PTK) tear function parameters, tear film lipid layer interferometry grade, goblet cell density, and conjunctival squamous metaplasia grade. Alterations of these parameters within 3 months after PTK were also looked for.
RESULTS: The average pre-PTK corneal sensitivity and tear film break up time were lower in patients compared with control subjects before PTK. Tear film lipid layer interferometry grade and conjunctival squamous metaplasia grades were higher in the patients than the controls before PTK. All these parameters improved gradually and significantly after PTK. Goblet cell density was significantly lower in the patients compared with controls before PTK. Schirmer test results and goblet cell density did not show any significant alterations after PTK.
CONCLUSIONS: Concurrent improvements in corneal sensitivity, tear film break up time, lipid layer interference grades, and conjunctival squamous metaplasia grades all point to the favorable effects of PTK on the ocular surface by improving the stability of the tear film and ocular surface health through attainment of a regular corneal surface and probably inducing qualitatively/quantitatively better mucin production by a healthier epithelium after PTK.

Entities:  

Mesh:

Year:  2000        PMID: 10857835     DOI: 10.1016/s0161-6420(00)00113-5

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  7 in total

Review 1.  Impression cytology of the ocular surface.

Authors:  R Singh; A Joseph; T Umapathy; N L Tint; H S Dua
Journal:  Br J Ophthalmol       Date:  2005-12       Impact factor: 4.638

2.  Excimer laser phototherapeutic keratectomy in eyes with anterior corneal dystrophies: preoperative and postoperative ultrasound biomicroscopic examination and short-term clinical outcomes with and without an antihyperopia treatment.

Authors:  Christopher J Rapuano
Journal:  Trans Am Ophthalmol Soc       Date:  2003

3.  Combined ethylenediaminetetraacetic acid chelation, phototherapeutic keratectomy and amniotic membrane transplantation for treatment of band keratopathy.

Authors:  Seong-Kyu Im; Kwang-Hoon Lee; Kyung-Chul Yoon
Journal:  Korean J Ophthalmol       Date:  2010-04-06

4.  Ocular surface changes and tear film alterations associated with sun gazing during a solar eclipse.

Authors:  Johannes Nepp; Guido T Dorner; Kerstin Jandrasits; Noemi Maar; Gebtraud Schild; Andreas Wedrich
Journal:  Wien Klin Wochenschr       Date:  2003-01-31       Impact factor: 1.704

Review 5.  Phototherapeutic keratectomy.

Authors:  Varsha M Rathi; Sharadini P Vyas; Virender S Sangwan
Journal:  Indian J Ophthalmol       Date:  2012 Jan-Feb       Impact factor: 1.848

6.  Phototherapeutic keratectomy outcomes in superficial corneal opacities.

Authors:  Khalid Al Arfaj; Vandana Jain; Mohamed Hantera; Mohamed Wagih El-Deeb; Adel Al Rushod; Akshay G Nair; Roberto Pineda
Journal:  Ophthalmol Eye Dis       Date:  2011-03-16

7.  Pentacam-based phototherapeutic keratectomy outcome in superficial corneal opacities.

Authors:  Mohammad A Rashad
Journal:  Clin Ophthalmol       Date:  2012-06-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.